Property, Plant and Equipment Property, Plant and Equipment

6 Months Ended

Jun. 30, 2020

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

Property, plant and equipment are recorded at historical cost, net of accumulated depreciation. Accumulated depreciation on property, plant and equipment was $1,687.0 million and $1,590.9 million as of June 30, 2020 and December 31, 2019, respectively. For the three and six months ended June 30, 2020, depreciation expense totaled $51.3 million and $99.7 million, respectively, compared to $47.0 million and $99.9 million, respectively, in the prior year comparative periods.

Solothurn, Switzerland Manufacturing Facility

In order to support our drug development pipeline, we are building a large-scale biologics manufacturing facility in Solothurn, Switzerland. We expect this facility to be partially operational by the end of 2020. Upon completion, this facility will include 393,000 square feet related to a large-scale biologics manufacturing facility, 290,000 square feet of warehouse, utilities and support space and 51,000 square feet of administrative space. As of June 30, 2020 and December 31, 2019, we had approximately $1.7 billion and $1.9 billion, respectively, capitalized as construction in progress related to this facility. For the six months ended June 30, 2020, we placed approximately $256.8 million of fixed assets in service related to this facility. As of June 30, 2020, we had contractual commitments of approximately $16.2 million outstanding related to the construction of this facility.